{"id":59462,"date":"2024-05-31T19:04:19","date_gmt":"2024-05-31T17:04:19","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/azuba-corporation-appoints-david-corso-as-evp-and-chief-revenue-officer\/"},"modified":"2024-05-31T19:04:19","modified_gmt":"2024-05-31T17:04:19","slug":"azuba-corporation-appoints-david-corso-as-evp-and-chief-revenue-officer","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/azuba-corporation-appoints-david-corso-as-evp-and-chief-revenue-officer\/","title":{"rendered":"Azuba Corporation Appoints David Corso as EVP and Chief Revenue Officer"},"content":{"rendered":"
\n

NAPERVILLE, Ill.–(BUSINESS WIRE)–Azuba (formerly Napersoft), a leading cloud-based health ecosystem that facilitates the exchange of lifetime patient clinical records for over 90% of all clinical data in the USA, is excited to announce the appointment of David Corso as its new Executive Vice President (EVP) and Chief Revenue Officer (CRO).<\/p>\n

<\/a>
<\/a>
<\/a>
<\/a><\/p>\n

\nLeveraging its Customer Communication Management (CCM) Platform, which serves more than 250 million Americans across major insurance payers, banking\/credit unions, and state governments, Azuba also automates via its Health Platform the retrieval and transmission of patients’ lifetime clinical data with a single click per year.<\/p>\n

\nDavid Corso brings over 30 years of executive experience in revenue operations from esteemed organizations such as UnitedHealthcare, Elevance Health, and the BlueCross BlueShield Association. In his new role, Corso will lead efforts to help Azuba\u2019s customers meet the demands for interoperability and patient access to their health information.<\/p>\n

\n“We are delighted to welcome David to the leadership team,” said Bart Carlson, CEO of Azuba. “His extensive background will be instrumental in accelerating the delivery of our clinical and communication solutions, which have facilitated billions of transactions since 1986.”<\/p>\n

\nToday, the lack of seamless data exchange leads to poor health outcomes. By enabling interoperable patient access to their health records with a single click, Azuba envisions a future where data is communicated freely and securely between payers, providers, and patients, leading to truly coordinated care, improved health outcomes, and reduced costs.<\/p>\n

\nCommenting on his new role, Corso expressed his enthusiasm for the transformative potential of Azuba\u2019s solutions. “Assuming the position of EVP and Chief Revenue Officer at Azuba presents an exceptional opportunity,” Corso stated. “Together, we will help our customers innovate and revolutionize how they lead our nation\u2019s promise to put patients first by liberating patients and giving them access to their health information when they need it most, and in a way they can best use it.\u201d<\/p>\n

\nWith David Corso’s appointment, Azuba is poised to embark on a new phase of accelerated expansion and growth. The company remains committed to delivering cutting-edge solutions that revolutionize the healthcare industry and drive cost savings while maintaining its standing as one of the most admired CCM Platform solutions in the healthcare sector.<\/p>\n

Contacts<\/b> <\/p>\n

\nDavid Corso
\n
david.corso@azuba.com<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

NAPERVILLE, Ill.–(BUSINESS WIRE)–Azuba (formerly Napersoft), a leading cloud-based health ecosystem that facilitates the exchange of lifetime patient clinical records for over 90% of all clinical data in the USA, is excited to announce the appointment of David Corso as its new Executive Vice President (EVP) and Chief Revenue Officer (CRO). Leveraging its Customer Communication Management … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-59462","6":"format-standard","7":"category-industry"},"yoast_head":"\nAzuba Corporation Appoints David Corso as EVP and Chief Revenue Officer - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/azuba-corporation-appoints-david-corso-as-evp-and-chief-revenue-officer\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Azuba Corporation Appoints David Corso as EVP and Chief Revenue Officer - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"NAPERVILLE, Ill.–(BUSINESS WIRE)–Azuba (formerly Napersoft), a leading cloud-based health ecosystem that facilitates the exchange of lifetime patient clinical records for over 90% of all clinical data in the USA, is excited to announce the appointment of David Corso as its new Executive Vice President (EVP) and Chief Revenue Officer (CRO). Leveraging its Customer Communication Management ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/azuba-corporation-appoints-david-corso-as-evp-and-chief-revenue-officer\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2024-05-31T17:04:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20240531247571\/en\/2146087\/22\/Azuba_2024-05-30_-_David_Corso_-_B-MedRes.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/azuba-corporation-appoints-david-corso-as-evp-and-chief-revenue-officer\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/azuba-corporation-appoints-david-corso-as-evp-and-chief-revenue-officer\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Azuba Corporation Appoints David Corso as EVP and Chief Revenue Officer\",\"datePublished\":\"2024-05-31T17:04:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/azuba-corporation-appoints-david-corso-as-evp-and-chief-revenue-officer\\\/\"},\"wordCount\":387,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/azuba-corporation-appoints-david-corso-as-evp-and-chief-revenue-officer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240531247571\\\/en\\\/2146087\\\/22\\\/Azuba_2024-05-30_-_David_Corso_-_B-MedRes.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/azuba-corporation-appoints-david-corso-as-evp-and-chief-revenue-officer\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/azuba-corporation-appoints-david-corso-as-evp-and-chief-revenue-officer\\\/\",\"name\":\"Azuba Corporation Appoints David Corso as EVP and Chief Revenue Officer - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/azuba-corporation-appoints-david-corso-as-evp-and-chief-revenue-officer\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/azuba-corporation-appoints-david-corso-as-evp-and-chief-revenue-officer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240531247571\\\/en\\\/2146087\\\/22\\\/Azuba_2024-05-30_-_David_Corso_-_B-MedRes.jpg\",\"datePublished\":\"2024-05-31T17:04:19+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/azuba-corporation-appoints-david-corso-as-evp-and-chief-revenue-officer\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/azuba-corporation-appoints-david-corso-as-evp-and-chief-revenue-officer\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/azuba-corporation-appoints-david-corso-as-evp-and-chief-revenue-officer\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240531247571\\\/en\\\/2146087\\\/22\\\/Azuba_2024-05-30_-_David_Corso_-_B-MedRes.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240531247571\\\/en\\\/2146087\\\/22\\\/Azuba_2024-05-30_-_David_Corso_-_B-MedRes.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/azuba-corporation-appoints-david-corso-as-evp-and-chief-revenue-officer\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Azuba Corporation Appoints David Corso as EVP and Chief Revenue Officer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Azuba Corporation Appoints David Corso as EVP and Chief Revenue Officer - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/azuba-corporation-appoints-david-corso-as-evp-and-chief-revenue-officer\/","og_locale":"en_US","og_type":"article","og_title":"Azuba Corporation Appoints David Corso as EVP and Chief Revenue Officer - Pharma Trend","og_description":"NAPERVILLE, Ill.–(BUSINESS WIRE)–Azuba (formerly Napersoft), a leading cloud-based health ecosystem that facilitates the exchange of lifetime patient clinical records for over 90% of all clinical data in the USA, is excited to announce the appointment of David Corso as its new Executive Vice President (EVP) and Chief Revenue Officer (CRO). Leveraging its Customer Communication Management ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/azuba-corporation-appoints-david-corso-as-evp-and-chief-revenue-officer\/","og_site_name":"Pharma Trend","article_published_time":"2024-05-31T17:04:19+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20240531247571\/en\/2146087\/22\/Azuba_2024-05-30_-_David_Corso_-_B-MedRes.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/azuba-corporation-appoints-david-corso-as-evp-and-chief-revenue-officer\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/azuba-corporation-appoints-david-corso-as-evp-and-chief-revenue-officer\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Azuba Corporation Appoints David Corso as EVP and Chief Revenue Officer","datePublished":"2024-05-31T17:04:19+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/azuba-corporation-appoints-david-corso-as-evp-and-chief-revenue-officer\/"},"wordCount":387,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/azuba-corporation-appoints-david-corso-as-evp-and-chief-revenue-officer\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20240531247571\/en\/2146087\/22\/Azuba_2024-05-30_-_David_Corso_-_B-MedRes.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/azuba-corporation-appoints-david-corso-as-evp-and-chief-revenue-officer\/","url":"https:\/\/pharma-trend.com\/en\/azuba-corporation-appoints-david-corso-as-evp-and-chief-revenue-officer\/","name":"Azuba Corporation Appoints David Corso as EVP and Chief Revenue Officer - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/azuba-corporation-appoints-david-corso-as-evp-and-chief-revenue-officer\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/azuba-corporation-appoints-david-corso-as-evp-and-chief-revenue-officer\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20240531247571\/en\/2146087\/22\/Azuba_2024-05-30_-_David_Corso_-_B-MedRes.jpg","datePublished":"2024-05-31T17:04:19+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/azuba-corporation-appoints-david-corso-as-evp-and-chief-revenue-officer\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/azuba-corporation-appoints-david-corso-as-evp-and-chief-revenue-officer\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/azuba-corporation-appoints-david-corso-as-evp-and-chief-revenue-officer\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20240531247571\/en\/2146087\/22\/Azuba_2024-05-30_-_David_Corso_-_B-MedRes.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20240531247571\/en\/2146087\/22\/Azuba_2024-05-30_-_David_Corso_-_B-MedRes.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/azuba-corporation-appoints-david-corso-as-evp-and-chief-revenue-officer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Azuba Corporation Appoints David Corso as EVP and Chief Revenue Officer"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/59462","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=59462"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/59462\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=59462"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=59462"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=59462"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}